![](/img/cover-not-exists.png)
P.07.1 SWITCHING FROM INFLIXIMAB ORIGINATOR TO A FIRST BIO SIMILAR IS SAFE AND EFFECTIVE. A SINGLE CENTER SERIES WITH THROUGH LEVELS AND ANTI-DRUG ANTIBODIES DETERMINATION
Daperno, M., Guiotto, C., Italia, A., Lavagna, A., Negri, A., Ercole, E., Cosimato, M., Rigazio, C., Rocca, R.Volume:
50
Language:
english
Journal:
Digestive and Liver Disease
DOI:
10.1016/s1590-8658(18)30551-6
Date:
March, 2018
File:
PDF, 359 KB
english, 2018